GEN Exclusives

More »

GEN News Highlights

More »
Nov 7, 2011

Horizon and Promega Ally on Cancer Models for Development of Targeted Drug Therapies

  • Horizon Discovery and Promega inked a partnership focused on developing a new generation of predictive human cancer models to aid in the development of targted drug therapies. The  program will combine Horizon’s homologous recombination-based rAAV genome editing technology, Genesis™, with Promega’s luciferase and HaloTag® reporter platforms to create endogenous gene reporting capabilities.

    Additionally, the firms will work together to develop in vivo xenograft models of Horizon's tumorigenic engineered isogenic cell lines with Promega reporter tags. The goal is to recapitulate genetic mutations exactly as they occur in patient tumors.

    Horizon has already used its Genesis platform to generate human cell lines carrying over 370 cancer mutations and variations as predictive in vitro models of genetic diseases. By adding in Promega’s reporter tags, the firms aim to generate in vivo xenografts of the tumorigenic isogenic cell lines. The firms say initial studies showed that the tagging technology generates exceptionally clear images of tumor graft response to targeted molecular therapies.

    The firm maintains the partnership will generate a resource for investigating the genetic drivers of disease to accelerate the discovery of targeted molecular therapies. “For the first time investigators will be able to directly trace the relationship between protein expression, the interaction of that target protein within its molecular pathway, and how it is encoded by the genome,” comments Paul Morrill, Ph.D., Horizon’s commercial director. 

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Patient Access to Genetic Information

Do you think patients have the absolute right to gain access to their own genetic information from medical or clinical laboratories?

More »